New AMSBIO product range includes a kit to facilitate rapid and efficient differentiation of human iPS or ES cells into skeletal muscle cells in just seven days
This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19
RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a wide range of ribonucleases to reliably protect RNA from RNase digestion
The combined Total Protein / Albumin Standard Kit and the Total Protein / Albumin Standard Level F, are specifically designed and manufactured for the calibration, and calibration verification, of albumin and total protein assays on a wide number of clinical testing systems
ImmunoRankoffers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins